{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:48:32Z","timestamp":1790153312901,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NHLBI P01 HL59412-06"],"award-info":[{"award-number":["NHLBI P01 HL59412-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIDDK P01 DK58327-03"],"award-info":[{"award-number":["NIDDK P01 DK58327-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HD052682-01A1"],"award-info":[{"award-number":["1R01HD052682-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHLBI Gene Therapy Resource Program"},{"name":"NICHD","award":["K12HD055929-02"],"award-info":[{"award-number":["K12HD055929-02"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.expneurol.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T11:17:39Z","timestamp":1469186259000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"P2","title":["Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity"],"prefix":"10.1016","volume":"287","author":[{"given":"Barbara K.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Daniel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Ann","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Vernot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley W.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.07.013_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/humc.2014.2514","article-title":"Phase I\/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease","volume":"25","author":"Byrne","year":"2014","journal-title":"Human Gene Therapy. Clinical Development"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0010","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc7927","article-title":"Determinants of weaning success in patients with prolonged mechanical ventilation","volume":"13","author":"Carlucci","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/hum.2010.230","article-title":"When ethics constrains clinical research: trial design of control arms in \u201cgreater than minimal risk:\u201d pediatric trials","volume":"22","author":"de Melo-Martin","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0020","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0025","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/mt.2013.96","article-title":"Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease","volume":"21","author":"Falk","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.nmd.2015.09.003","article-title":"Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: new insights from a comparative study by MRI and respiratory function assessment","volume":"25","author":"Gaeta","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.2000.89.2.695","article-title":"Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers","volume":"89","author":"Geiger","year":"2000","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ppul.20905","article-title":"Measurement of maximal inspiratory pressure in ventilated children","volume":"43","author":"Harikumar","year":"2008","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/PRM-140294","article-title":"Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness","volume":"7","author":"Jones","year":"2014","journal-title":"J. Pediatr. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2016.07.013_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ymgme.2015.09.003","article-title":"Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining","volume":"117","author":"Jones","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0060","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","article-title":"Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein","volume":"93","author":"Kessler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.resp.2010.07.001","article-title":"Diaphragm motor unit recruitment in rats","volume":"173","author":"Mantilla","year":"2010","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/japplphysiol.01087.2002","article-title":"Noninvasive measurement of the tension-time index in children with neuromuscular disease","volume":"95","author":"Mulreany","year":"2003","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"Nicolino","year":"2009","journal-title":"Genitourin. Med."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0095","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1109\/10.335860","article-title":"Long-term intramuscular electrical activation of the phrenic nerve: safety and reliability","volume":"41","author":"Peterson","year":"1994","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genitourin. Med."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4187\/respcare.03001","article-title":"What are the implications of blunted load compensation responses in prolonged-weaning patients?","volume":"59","author":"Sassoon","year":"2014","journal-title":"Respir. Care"},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2016.07.013_bb0120","first-page":"S42","article-title":"Autophagy in skeletal muscle: implications for Pompe disease","volume":"47","author":"Shea","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.124.1.262","article-title":"Cough peak flows and extubation outcomes","volume":"124","author":"Smina","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/hum.2012.250","article-title":"Phase I\/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in pompe disease: initial safety and ventilatory outcomes","volume":"24","author":"Smith","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4187\/respcare.02053","article-title":"Effect of training on inspiratory load compensation in weaned and unweaned mechanically ventilated ICU patients","volume":"59","author":"Smith","year":"2014","journal-title":"Respir. Care"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.resp.2015.11.013","article-title":"Altered activation of the diaphragm in late-onset Pompe disease","volume":"222","author":"Smith","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.07.013_bb0145","doi-asserted-by":"crossref","unstructured":"Smith, B. K., Fuller, D.D., Martin, A.D., Lottenberg, L., Islam, S., Lawson, L.A., Onders, R.P., Byrne, B.J., 2016b. Diaphragm pacing as a rehabilitative tool for patients with Pompe disease who are ventilator-dependent: Case series. Phys. Ther. 96, 696\u2013703.","DOI":"10.2522\/ptj.20150122"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.expneurol.2016.07.013_bb0160","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616302126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616302126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T09:48:14Z","timestamp":1582537694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616302126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"alternative-id":["S0014488616302126"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.07.013","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}